Mega Lifesciences Public : Interim dividend payment 2022
August 11, 2022 at 06:54 am
Share
Headline:
Interim dividend payment 2022
Security Symbol:
MEGA
Announcement Details
Dividend payment / Omitted dividend payment
Subject
Cash dividend payment
Date of Board resolution
11-Aug-2022
Type of dividend payment
Cash dividend payment
Record date for the right to receive dividends
25-Aug-2022
Ex-dividend date
24-Aug-2022
Payment for
Common shareholders
Cash dividend payment (baht per share)
0.75
Derived from profit under non-BOI privilege (baht per share)
0.15
Derived from profit under BOI privilege (baht per share)
0.60
Par value (baht)
0.50
Payment date
09-Sep-2022
Paid from
Operating period from 01-Jan-2022 to
30-Jun-2022 and Retained Earnings
The company hereby certifies that the information above is correct and complete.
Signature _________________
Signature _________________
(Mr.Vivek Dhawan)
(Mr.Thomas Abraham)
Director
Director
Authorized Persons to Disclose
Authorized Persons to Disclose
Information
Information
Remark
Interim dividend payment 2022
This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Mega Lifesciences pcl published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 10:53:18 UTC.
Mega Lifesciences Public Company Limited is a Thailand-based company. The Company is engaged in manufacturing and selling through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods, as well as the provision of distribution services relating to such products. Its segments include Brands, Distribution, and OEM (Original Equipment Manufacturer). The Brands segment represents a business segment in which goods are manufactured and sold under brands owned by the Company. The Distribution segment represents a service business segment in which the Company provides logistical and marketing services for goods trading purposes and the sale of goods manufactured by third parties. The OEM segment represents a business segment in which goods are manufactured by third parties under brands not owned by the Company.